ripekg:author/RIPEAU440E25D0FE4FD4EBWei-Hao Xie |
rdf:type |
node1 |
ripekg:author/RIPEAU440E25D0FE4FD4EBWei-Hao Xie |
rdf:type |
rdfs:Resource |
ripekg:author/RIPEAU440E25D0FE4FD4EBWei-Hao Xie |
rdf:type |
owl:Thing |
ripekg:author/RIPEAU440E25D0FE4FD4EBWei-Hao Xie |
rdf:type |
prov:Person |
ripekg:author/RIPEAU440E25D0FE4FD4EBWei-Hao Xie |
rdf:type |
foaf:Person |
ripekg:author/RIPEAU440E25D0FE4FD4EBWei-Hao Xie |
rdf:type |
ripe:AuthorAuthor |
ripekg:author/RIPEAU440E25D0FE4FD4EBWei-Hao Xie |
owl:sameAs |
https://semopenalex.org/author/A5103844080 |
ripekg:author/RIPEAU440E25D0FE4FD4EBWei-Hao Xie |
foaf:familyName |
Xie |
ripekg:author/RIPEAU440E25D0FE4FD4EBWei-Hao Xie |
foaf:givenName |
Wei-Hao |
ripekg:author/RIPEAU440E25D0FE4FD4EBWei-Hao Xie |
foaf:name |
Wei-Hao Xie |
ripekg:work/10.1136%2Fbmj-2024-081557Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial |
dcterms:creator |
ripekg:author/RIPEAU440E25D0FE4FD4EBWei-Hao Xie |